Ezetimibe reduces cardiovascular events in diabetics with recent acute coronary syndrome
Ezetimibe reduces cardiovascular events in patients with diabetes and a recent acute coronary syndrome, according to a subgroup analysis of the IMPROVE-IT trial presented at ESC Congress today by co-principal investigator ...
Aug 30, 2015
0
7